AMG487 alleviates influenza A (H1N1) virus‐induced pulmonary inflammation through decreasing IFN‐γ‐producing lymphocytes and IFN‐γ concentrations
British Journal of Pharmacology · 2024-07 · 181 (13) · 2053-2069
DOI: 10.1111/bph.16343 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, online erschienen am 18.03.2024. Verfasst von Wenbin Ding und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University…. Hauptthemen laut MEDLINE: Influenza A Virus, H1N1 Subtype, Interferon-gamma, Orthomyxoviridae Infections, Lymphocytes. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China, The grant of State Key Laboratory of Respiratory Disease.
Abstract (Originalsprache)
Background and Purpose Severe influenza virus‐infected patients have high systemic levels of Th1 cytokines (including IFN‐γ). Intrapulmonary IFN‐γ increases pulmonary IFN‐γ‐producing T lymphocytes through the CXCR3 pathway. Virus‐infected mice lacking IP‐10/CXCR3 demonstrate lower pulmonary neutrophilic inflammation. AMG487, an IP‐10/CXCR3 antagonist, ameliorates virus‐induced lung injury in vivo through decreasing viral loads. This study examined whether AMG487 could treat H1N1 virus‐induced mouse illness through reducing viral loads or decreasing the number of lymphocytes or neutrophils. Experimental Approach Here, we studied the above‐mentioned effects and underlying mechanisms in vivo. Key Results H1N1 virus infection caused bad overall condition and pulmonary inflammation characterized by the infiltration of lymphocytes and neutrophils. From Day‐5 to Day‐10 post‐virus infection, bad overall condition, pulmonary lymphocytes, and IFN‐γ concentrations increased, while pulmonary H1N1 viral titres and neutrophils decreased. Both anti‐IFN‐γ and AMG487 alleviated virus infection‐induced bad overall condition and pulmonary lymphocytic inflammation. Pulmonary neutrophilic inflammation was mitigated by AMG487 on Day‐5 post‐infection, but was not mitigated by AMG487 on Day‐10 post‐infection. H1N1 virus induced increases of IFN‐γ, IP‐10, and IFN‐γ‐producing lymphocytes and activation of the Jak2‐Stat1 pathways in mouse lungs, which were inhibited by AMG487. Anti‐IFN‐γ decreased IFN‐γ and IFN‐γ‐producing lymphocytes on Day‐5 post‐infection. AMG487 but not anti‐IFN‐γ decreased viral titres in mouse lung homogenates or BALF. Higher virus load did not increase pulmonary inflammation and IFN‐γ concentrations when mice were treated with AMG487. Conclusion and Implications AMG487 may ameliorate H1N1 virus‐induced pulmonary inflammation through decreasing IFN‐γ‐producing lymphocytes rather than reducing viral loads or neutrophils.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
ORCID-Profile: Zheng Deng
Förderung
- National Natural Science Foundation of China
- The grant of State Key Laboratory of Respiratory Disease
Zitieren
APA
Ding, W., Li, R., Song, T., Yang, Z., Xu, D., Huang, C., Shen, S., Zhong, N., Lai, K., & Deng, Z. (2024). AMG487 alleviates influenza A (H1N1) virus‐induced pulmonary inflammation through decreasing IFN‐γ‐producing lymphocytes and IFN‐γ concentrations. British Journal of Pharmacology, 181(13), 2053-2069. https://doi.org/10.1111/bph.16343
Vancouver
Ding W, Li R, Song T, Yang Z, Xu D, Huang C, et al. AMG487 alleviates influenza A (H1N1) virus‐induced pulmonary inflammation through decreasing IFN‐γ‐producing lymphocytes and IFN‐γ concentrations. British Journal of Pharmacology. 2024;181(13):2053-2069. doi:10.1111/bph.16343
BibTeX
@article{Ding2024,
author = {Ding, Wenbin and Li, Runfeng and Song, Tongtong and Yang, Zifeng and Xu, Dongting and Huang, Chuqin and Shen, Shuirong and Zhong, Nanshan and Lai, Kefang and Deng, Zheng},
title = {AMG487 alleviates influenza A (H1N1) virus‐induced pulmonary inflammation through decreasing IFN‐γ‐producing lymphocytes and IFN‐γ concentrations},
journal = {British Journal of Pharmacology},
year = {2024},
volume = {181},
number = {13},
pages = {2053--2069},
doi = {10.1111/bph.16343}
}
EUVIMED